Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1066-1072

  Dittadi, Ruggero ^a   Meo, Sabrina ^a   Amoroso, Barbara ^b   Gion, Massimo ^a  

^a Ctro Regionale Specializzato P   (Italy)

^b ABBOTT DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOSOL; ENZYME IMMUNOASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; BUFFERS; CYTOSOL; ESTRADIOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM PROTEINS; POTASSIUM CHLORIDE; PROTEIN BINDING; RADIOLIGAND ASSAY; REAGENT KITS, DIAGNOSTIC; RECEPTORS, ESTROGEN; SENSITIVITY AND SPECIFICITY;

EID: 0030992404     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Thorpe, S. M. Estrogen and progesterone receptor determinations in breast cancer: technology, biology and clinical significance. Acta Oncol., 27: 1-19, 1988
2. Fisher, B., Redmond, C., Fisher, E. T., Caplan, R., and other contributing National Surgical Adjuvant Breast and Bowel Project investigators. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J. Clin. Oncol, 6: 1076-1087, 1988.
3. Donegan, W. L. Prognostic factors: stage and receptor status in breast cancer. Cancer 70 (Suppl.): 1755-1764, 1992.
4. Nomura, Y., Miura, S., Koyama, H., Enomoto, K., Kasumi, F., Yamamoto, H., Kimura, M., Tominaga, T., Iino, H., Morimoto, T., and Tashiro, H. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. Cancer (Phila.), 69: 153-164, 1992.
5. Henderson, I. C. Endocrine therapy in metastatic breast cancer. In: J. R. Harris, S. Hellman, I. C. Henderson, and D. W. Kenne (eds.), Breast Diseases. Philadelphia: J. B. Lippincott, pp. 398-428, 1987.
6. Rose, C., Thorpe, S. M., Andersen, K. W., Pedersen, B. W., Mouridsen, H. T., Blichert-Toft, M., and Rasmussen, B. B. Beneficial effect of tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet, i: 16-19, 1985.
7. Chamness, G. C., and McGuire, W. L. Methods for analyzing steroid receptors in human breast cancer. In: W. L. McGuire (eds,). Breast Cancer 3: Advances in Research and Treatment, Current Topics, pp. 149-197. New York: Plenum Publishing Corp., 1980.
8. EORTC Breast Cancer Cooperative Group. Standards for the assessment of estrogen receptor receptors in human breast cancer. Eur. J. Cancer Clin. Oncol., 9: 379-381, 1973.
9. Koenders, T., and Thorpe, S. M., on behalf of the EORTC Receptor Group. Standardization of steroid receptor assays in human breast cancer. I. Reproducibility of estradiol and progesterone receptor assays. Eur. J. Cancer Clin. Oncol., 19: 1221-1229, 1983.
10. EORTC Breast Cancer Cooperative Group. Revision of the standards for the assessments of hormone receptors in human breast cancer. Eur. J. Cancer, 16: 1513-1515, 1980.
11. Greene, G. L., Nolan, C., Engler, J. P., and Jensen, E. V. Monoclonal antibodies to the human estrogen receptor. Proc. Nail. Acad. Sci. USA, 77: 5115-5119, 1980.
12. Greene, G. L., and Press, M. F. Application of monoclonal antibodies against estrogen and progesterone receptors in the immunocytochemical evaluation of breast carcinomas. In: R. L. Ceriani (eds.). Immunological Approaches to the Diagnosis and Therapy of Breast Cancer, pp. 1-17. New York: Plenum Publishing Corp., 1987,
13. Greene, G. L., Sobel, N. B., King, W. J., and Jensen, E. V. Immunochemical studies of estrogen receptors. Steroid Biochem., 20: 51-56, 1984.
14. Craig Jordan, V., Jacobson, H. I., and Keenan, E. J. Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United States. Cancer Res., 46: 4237-4240, 1986.
15. Nicholson, R. I., Colin, P., Barrie Francis, A. B., Keshra, R., Finlay, P., Williams, M., Elston, C. W., Blarney, R. W., and Griffiths, K. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers. Cancer Res., 46: 4299-4302, 1986.
16. Mobbs, B. G., and Johnson, I. E. Use of an enzyme immunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer. J. Steroid Biochem., 28: 653-662, 1987.
17. Bozzetti, C., Naldi, N., Guazzi, A., Nizzoli, R., Benecchi, M. and Cocconi, G. Determination of estrogen receptors in human breast cancer: comparison between enzyme immunoassay and dextran-coated charcoal method. Tumori, 72: 511-514, 1986.
18. Goussard, J., Lechevrel, C., Martin, P. M., and Roussel, G. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols. Cancer Res., 46: 4282-4287, 1986.
19. Leclercq, G., Bojar, H., Goussard J., Nicholson, R. I., Pichon, M-F., Piffanelli, A., Pousette, A., Thorpe, S., and Lonsdorfer, M. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicentric study. Cancer Res., 46: 4233-4236, 1986.
20. Blankenstein, M. A. Comparison of ligand binding assay and enzyme immunoassay of estrogen receptor in human breast cancer cytosols. Experience of the EORTC Receptor Group. Breast Cancer Res. Treat., 77: 91-98, 1990.
21. Thorpe, S. M. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method. Cancer Res., 47: 6572-6575, 1987.
22. Andersen, J., Bentzen, S. M., and Poulsen, H. S. Relationship between radioligand binding assay for estrogen receptors in human breast cancer and association with tumor differentiation. Eur. J. Cancer Clin. Oncol., 24: 377-384, 1988.
23. Holmes, F. A., Fritsche, H. A., Loewy, J. W., Geitner, A. M., Sutton, R. C., Buzdar, A. U., and Hortobagyi, G. N. Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay. J. Clin. Oncol., 8: 1025-1035, 1990.
24. Romain, S., Dussert, C., and Martin, P. M. Determination of oestrogen receptors: application of the Passing-Bablock linear regression technique for comparison of enzyme immunoassay and radioligand binding assay in 1841 breast cancer tumors. Eur. J. Cancer, 27: 715-720, 1991.
25. Gion, M., Dittadi, R., Leon, A. E., Bruscagnin, G., Pelizzola, D., Giovannini, G., Giganti, M., Messen, G., Quercioli, M., Flamini, E., Riccobon, A., Bozzetti, C., Benecchi, M., De Lena, M., Paradiso, A., Ruggeri, G., Luisi, P., and Piffanelli, A. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study. Eur. J. Cancer, 27: 996-1002, 1991.
26. Di Fronzo, G., Miodini, P., Brivio, M., Cappelletti, V., Coradini, D., Granata, G., and Ronchi, E. Comparison of immunochemical and radioligand binding assays for estrogen receptors in human breast tumors. Cancer Res., 46: 4278s-4281s, 1986.
27. Farque, F., Lluch, A., Vizcarra, E., Munoz, M., Alberola, V., and Garcia-Conde, J. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method. Oncology, 57: 435-439, 1994.
28. Raam, S., and Vrabel, D. M. Evaluation of an enzyme immunoassay kit for estrogen receptor measurements. Clin. Chem., 32: 1496-1502, 1986.
29. Raam, S. Hormone free estrogen receptors in target cell nuclei: a commentary. Steroids, 47: 4-5, 1986.
30. Hyder, S. M., Sato, N., Meyer, J. S., and Wittliff, J. L. Recognition of estrogen receptor isoforms from human breast cancer by immobilized monoclonal antibodies. Tumor Diagnostik Therapie, 9: 233-241, 1988.
31. Foekens, J. A., Portengen, H., van Putten, W. L. J., Peters, H. A., Krijnen, H. L. J. M., Alexieva-Figusch, J., and Klijn, J. G. M. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Res., 49: 5823-5828, 1989.
32. Romain, S., Dussert, C., and Martin, P. M. Determination of oestrogen receptors: application of the passing-bablock linear regression technique for comparison of enzyme and radioligand binding assay in 1841 breast cancer tumours. Eur. J. Cancer, 27: 715-720, 1991.
33. Piffanelli, A., Fumero, S., Pelizzola, D., Berruto, G. P., Ricci, L., and Giovannini, G. Protocollo del metodo con charcoal-destrano (D. C. C.) per il dosaggio dei recettori dell'estradiolo e del progesterone nel tessuto neoplastico. J. Res. Lab. Med., 9: 13-21, 1982.
34. Agrimonti, F., Berruto, G. P., Fornaro, D., De Bortoli, M., Fumero, S., Frairia, R., Pelizzola, D., Giovannini, G., and Piffanelli, A. Quality control for estrogen and progesterone receptor assay in human breast cancer: the influence of computation methods on intra and interlaboratory variability. Tumori, 71: 597-602, 1985.
35. Giambiagi, N., and Pasqualini, J. R. Interaction of three monoclonal antibodies with the nonactivated and activated forms of the estrogen receptor. Endocrinology, 726: 1403-1409, 1991.
36. Giambiagi, N., Pasqualini, J. R. Immunorecognition of the active form of the oestrogen receptor by using a monoclonal antibody. Biochem. J., 230: 203-210, 1985.
37. Gion, M., Colombo, L., Dittadi, R., Mione, R., and Bruscagnin, G. Relationship between receptor status and cytosol levels of El, E2, E3 and DHAS in breast carcinoma. Ann. NY Acad. Sci., 464: 514-516, 1986.
38. Abdul Haij, Y. J. Relationship between estrogen receptors, 17β-hydroxysteroid dehydrogenase and estrogen content in human breast cancer. Steroids, 34: 217-220, 1979.
39. Markaverich, B. M., and Clark, J. H. Two binding sites for estradiol in rat urine nuclei: relationship to uterotropic response. Endocrinology, 705: 1458-1462, 1979.
40. Garola, R. E., and McGuire, W. L. Estrogen receptor and proteolytic activity in human breast tumor nuclei. Cancer Res., 37: 3329-3332, 1977.
41. Love, C. A., Cowan, S. K., Laing, L. M., and Leake, R. E. Stability of the human nuclear oestrogen receptor: influence of temperature and ionic strength. J. Endocrinol., 99: 423-433, 1983.